Low TS protein expression and clinical response in pemetrexed/platinum agents treated mesothelioma patients has been controversial [103, 104, 105] and no correlation has been observed in vitro between TS expression and pemetrexed sensitivity in mesothelioma cell lines [104]. The gene discussed is TYMS; the disease is mesothelioma.